Characteristics of HIV-Infected Women Who Do Not Receive Preventive Antiretroviral Therapy in the French Perinatal Cohort

Journal of Acquired Immune Deficiency Syndromes

Volumn 34, Issue 3, 2003, Pages 338-343

  Mayaux, Marie Jeanne ^a,c   Teglas, Jean Paul ^a   Blanche, Stephane ^b  

^a INSERM   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c BICÊTRE HOSPITAL   (France)

Author keywords

AIDS; Pregnancy; Untreated woman

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; ZIDOVUDINE;

ADULT; AFRICA; ARTICLE; ARTIFICIAL MILK; BREAST FEEDING; CESAREAN SECTION; COHORT ANALYSIS; CONTROLLED STUDY; EUROPE; FEMALE; FRANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; PERINATAL INFECTION; POLYMERASE CHAIN REACTION; PREGNANCY; PREMATURE LABOR; PRESCHOOL CHILD; PREVENTIVE MEDICINE; PRIORITY JOURNAL; SEXUAL TRANSMISSION; SOCIOECONOMICS; VERTICAL TRANSMISSION;

ADULT; COHORT STUDIES; DISEASE TRANSMISSION, VERTICAL; DNA, VIRAL; FEMALE; FRANCE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE INHIBITORS; ZIDOVUDINE;

EID: 0242664915     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200311010-00013     Document Type: Article

References (15)

1. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type I with zidovudine treatment. N Engl J Med. 1994;331:1173-1180.
2. Mandelbrot L, Landreau-Mascaro A, Rekacewicz C, et al. Lamivudinezidovudine combination for prevention of maternal-infant transmission of HIV-1. JAMA. 2001;285:2083-2093.
3. Morris AB, Cu-Uvin S, Harwell JI, et al. Multicenter review of protease inhibitors in 89 pregnancies. J Acquir Immune Defic Syndr. 2000;25:306-311.
4. Bucceri AM, Somigliana E, Matrone R, et al. Combination therapy in 100 HIV-1-infected pregnant women. Hum Reprod. 2002;17:436-441.
5. Cooper ER, Charurat M, Mofenson L, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1 infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr. 2002;29:484.
6. Mofenson L. Antiretroviral therapy and interruption of HIV perinatal transmission. Immunol Allergy Clin North Am. 1998;18:441-460.
7. Culnane M, Fowler M, Lee SS, et al. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatrics AIDS Clinical Trials Group Protocol 219/076 Teams. JAMA. 1999;281:151-157.
8. Blanche S, Tardieu M, Rustin P, et al. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. The Lancet. 1999;354:1084-1089.
9. Lallemant M, Jourdain G, Le Cœur S, et al, for the Perinatal HIV Prevention Trial (Thailand) Investigators. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. N Engl J Med. 2000;343:982-991.
10. Perinatal HIV Guidelines Working Group. Public health service task force recommendations for the use of antiretroviral drugs in pregnant HIV-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. May 4, 2001. Available at http://www.AIDSinfo.nih.gov.
11. Lyall EG, Blott M, de Ruiter A, et al. British HIV Association. Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission. HIV Med. 2001;2:314-334.
12. Delfraissy JF. Prise en charge thérapeutique des personnes infectées parle VIH. Paris: Flammarion; 2000.
13. Mayaux MJ, Blanche S, Rouzioux C, et al. Maternal factors associated with perinatal HIV-1 transmission: The French Cohort Study: 7 years of follow-up observation. J Acquir Immune Defic Syndr. 1995;8:188-194.
14. Couturier E, Brossard Y, Larsen C, et al. HIV infection at outcome of pregnancy in the Paris area, France. The Lancet. 1992;340:70-79.
15. European Center for the Epidemiological Monitoring of AIDS. HIV/AIDS surveillance in Europe. Quarterly report 54. June 30, 1997. Available at http://www.eurohiv.org.